Vitamin K Deficiency Symptoms: Causes, Lab Markers, and Evidence-Based Supplement Support

Vitamin K Deficiency Symptoms: Causes, Lab Markers, and Evidence-Based Supplement Support

Most people associate vitamin K with blood clotting — and stop there. But that single-function view misses an enormous part of the story. Vitamin K is a fat-soluble cofactor for at least 17 known proteins in the human body, governing everything from how your bones mineralize to whether calcium ends up in your arteries or your skeleton. When levels fall short, the consequences extend across cardiovascular health, bone density, insulin sensitivity, and even cognitive function.

What makes deficiency especially tricky to catch is that standard coagulation panels — PT and INR — only become abnormal when deficiency is already severe. Meanwhile, subclinical insufficiency has been accumulating damage for years. This article walks through the full symptom spectrum, which lab markers actually capture early insufficiency, what causes the shortfall in the first place, and the evidence behind targeted supplementation.

---

What Vitamin K Actually Does in the Body

Vitamin K acts as an enzyme cofactor in a process called gamma-carboxylation. This post-translational modification activates specific proteins — called vitamin K-dependent proteins (VKDPs) — by adding a carboxyl group to glutamic acid residues, allowing them to bind calcium. Without sufficient K, these proteins remain undercarboxylated and functionally inactive.

The two most clinically relevant VKDPs outside coagulation are:

• Osteocalcin — produced by osteoblasts; required for calcium incorporation into bone matrix. Undercarboxylated osteocalcin (ucOC) is a direct biomarker of vitamin K insufficiency.
• Matrix Gla Protein (MGP) — synthesized in vascular smooth muscle and cartilage; when fully carboxylated, MGP actively inhibits vascular and soft-tissue calcification. Undercarboxylated MGP (ucMGP) is elevated in vitamin K deficiency and is strongly associated with arterial stiffness and cardiovascular risk (Schurgers et al., Journal of Nutrition 2007; PMID: 17951475).

Vitamin K exists in two primary dietary forms: K1 (phylloquinone), concentrated in green leafy vegetables, and K2 (menaquinones), found in fermented foods and animal products. The MK-7 form of K2 has a significantly longer half-life (~72 hours vs. ~1–2 hours for K1), meaning it reaches extrahepatic tissues — bones and blood vessels — far more effectively (Schurgers & Vermeer, Haemostasis 2000; PMID: 11356998).

---

Recognizing Vitamin K Deficiency Symptoms

Symptoms exist on a spectrum from subclinical insufficiency to overt deficiency. Most adults in the Western world sit somewhere in the middle — enough K1 from diet to prevent dangerous bleeding, but insufficient K2 to fully activate MGP and osteocalcin.

Early and subclinical signs:

• Easy bruising with minimal trauma
• Slow-healing wounds and cuts
• Heavy or prolonged menstrual bleeding
• Gum bleeding during brushing
• Increased dental tartar or calculus formation
• Mild bone tenderness or low back ache

Signs of deeper insufficiency:

• Reduced bone mineral density (BMD) detectable on DEXA scan
• Increased fracture risk, particularly in postmenopausal women (Booth et al., Journal of Nutrition 2003; PMID: 12949381)
• Arterial stiffness and elevated pulse pressure
• Soft tissue and aortic calcification visible on imaging
• Worsening insulin sensitivity — osteocalcin has a direct endocrine role in regulating insulin secretion and glucose uptake (Ferron et al., Cell 2008; PMID: 18692468)

Groups at elevated risk:

• People taking warfarin or other vitamin K antagonists
• Individuals on broad-spectrum antibiotics (which reduce K2-producing gut bacteria)
• Those with fat malabsorption syndromes: Crohn's disease, celiac disease, short bowel syndrome, or cholestasis
• People with chronic kidney disease (CKD), where vascular calcification from ucMGP is a leading cause of cardiovascular mortality
• Older adults on low-fat diets who avoid K1-rich vegetables
• Anyone taking high-dose vitamin D3 without co-supplementing K2 — D3 upregulates VKDPs, increasing K demand (NIH Office of Dietary Supplements, Vitamin K Fact Sheet for Health Professionals)

If you're currently supplementing vitamin D3 and K2 together, understanding how these two nutrients interact is critical for getting the dosing right — particularly the form and dose of K2 that actually activates MGP.

---

Lab Markers That Actually Detect Vitamin K Insufficiency

Routine coagulation tests (PT, INR, aPTT) are hepatic markers — they reflect liver K1 status and only deviate from normal when deficiency is severe. For functional insufficiency, you need tissue-specific markers:

Dp-ucMGP is now considered the gold-standard biomarker for vitamin K2 tissue status (Dalmeijer et al., European Journal of Clinical Nutrition 2012; PMID: 22166897). Some functional medicine labs and platforms that analyze comprehensive biomarker panels — similar to what Ones ingests when you upload your blood work — can flag elevations in these markers and adjust your formula accordingly.

---

Vitamin D3 Deficiency Symptoms and the K2 Connection

Vitamin K deficiency and vitamin D3 deficiency share overlapping symptom profiles, and understanding this relationship matters clinically. Symptoms of vitamin D3 deficiency include fatigue, bone pain, muscle weakness, frequent infections, and mood disturbances — many of which also worsen when K2 is low because D3 and K2 operate on the same downstream proteins.

Vitamin D3 increases the synthesis of osteocalcin and MGP. If K2 is insufficient, the additional VKDPs that D3 stimulates remain undercarboxylated — meaning high-dose D3 supplementation without K2 can paradoxically worsen soft-tissue calcification and impair bone matrix quality (Masterjohn, Medical Hypotheses 2007; PMID: 17145139). This is why clinical experts consistently recommend pairing D3 with MK-7 form K2, particularly at D3 doses of 2,000 IU or above.

A 3-year randomized controlled trial in postmenopausal women found that combined vitamin D3 + K2 (MK-7 180 mcg/day) significantly reduced age-related bone stiffness loss compared to placebo, while D3 alone showed no significant effect (Knapen et al., Osteoporosis International 2013; PMID: 23525894). This synergy is why Ones bundles Vitamin D3 + K2 (MK-7) as a paired formula component rather than offering them as isolated ingredients.

---

Vitamin A Deficiency Symptoms and Fat-Soluble Vitamin Interplay

Vitamin A deficiency symptoms — night blindness, dry skin, poor immune function, and impaired wound healing — signal a broader problem: fat-soluble vitamin depletion. Because vitamins A, D, E, and K are all fat-soluble, any condition that impairs fat absorption (bile acid insufficiency, inflammatory bowel disease, very-low-fat diets) tends to deplete all four simultaneously.

This is more than a coincidence. Vitamins A and K2 share a regulatory relationship: vitamin A (retinoic acid) modulates gene expression of several VKDPs, including osteocalcin. Animal and in vitro research suggests that excessive retinoic acid can interfere with vitamin K activation pathways, while adequate combined levels support bone and immune health synergistically (NIH Office of Dietary Supplements, Vitamin A Fact Sheet). Clinically, if a patient presents with vitamin A deficiency symptoms, it warrants assessment of K2, D3, and E status simultaneously — not just retinoic acid repletion in isolation.

For people with fat malabsorption, supplementing fat-soluble vitamins in their most bioavailable forms — such as MK-7 for K2 and retinyl palmitate for A — significantly improves absorption compared to synthetic or esterified forms.

---

Vitamin B1 Deficiency Symptoms: A Different Pathway Worth Knowing

Vitamin B1 (thiamine) deficiency symptoms — fatigue, peripheral neuropathy, cognitive difficulty, heart palpitations, and in severe cases, Wernicke's encephalopathy — arise from a completely different mechanism than K deficiency, but they're worth addressing here because they frequently co-occur in populations with poor dietary diversity or chronic alcohol use.

Thiamine is a water-soluble B vitamin that serves as a cofactor for several mitochondrial enzymes, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Deficiency impairs glucose metabolism at the cellular level, particularly in the nervous system and cardiac tissue. High carbohydrate intake without sufficient thiamine accelerates depletion — a clinically important point for individuals relying heavily on refined grains (NIH Office of Dietary Supplements, Thiamine Fact Sheet for Health Professionals).

Unlike vitamin K, thiamine deficiency is detectable through erythrocyte transketolase activity and whole-blood thiamine levels. Understanding both B-vitamin and fat-soluble vitamin deficiencies is a reminder that comprehensive lab analysis — not single-nutrient testing — gives the clearest picture of nutritional status.

---

Vitamin B6 Deficiency Symptoms and Inflammatory Overlap

Vitamin B6 deficiency symptoms — including peripheral neuropathy, dermatitis, glossitis, irritability, confusion, and impaired immune function — overlap meaningfully with vitamin K insufficiency in one key domain: inflammation. Both deficiencies are associated with elevated inflammatory markers, including CRP and IL-6, and both worsen with aging, chronic disease, and medications (specifically oral contraceptives and isoniazid for B6; antibiotics and warfarin for K).

Pyridoxal-5-phosphate (P5P), the active form of B6, is required for over 100 enzymatic reactions, including neurotransmitter synthesis, homocysteine metabolism, and immune cell proliferation. Elevated homocysteine — a known risk factor for cardiovascular disease and arterial damage — is worsened by both B6 deficiency and vitamin K2 insufficiency, since arterial inflammation accelerates the vascular calcification that ucMGP is supposed to prevent. Correcting both deficiencies simultaneously is therefore more protective than addressing either alone (Selhub et al., American Journal of Clinical Nutrition 1993; PMID: 8480666).

If your wearable data shows chronic elevated resting heart rate or poor heart rate variability — signals that Ones ingests when analyzing your health history — it's worth investigating both B6 and K2 status as contributing factors to vascular and autonomic health.

---

How Ones Addresses Vitamin K Insufficiency

Ones is built on the premise that no two people have the same deficiency profile — and vitamin K is one of the clearest examples of why. Someone taking 5,000 IU of D3 daily without K2 has a fundamentally different risk profile than someone with fat malabsorption or chronic antibiotic use. Ones addresses this by analyzing your uploaded blood work, wearable data, and health history through its AI health practitioner to identify where your K status actually sits — and what your formula needs.

Here's how specific Ones ingredients map to the clinical evidence for K insufficiency:

1. Vitamin D3 + K2 (MK-7) — paired and dosed to clinical ranges

Ones includes Vitamin D3 alongside K2 in the MK-7 form, the bioavailable long-half-life menaquinone used in the Knapen 2013 RCT (180 mcg MK-7 for bone stiffness outcomes; PMID: 23525894). Rather than offering these as two separate capsules with generic doses, Ones calibrates both based on your 25-OH-D3 blood level and flags K2 co-dosing need when D3 is elevated without K2 present in your current regimen.

2. Magnesium Glycinate (via Magnesium Complex system blend)

Magnesium is a co-factor in vitamin D activation and is required for converting inactive vitamin D to its active 1,25(OH)2D form — meaning low magnesium limits D3's ability to drive VKDP synthesis. Ones includes magnesium glycinate for sleep and cellular function at clinically relevant doses, addressing the upstream deficiency that can blunt K2's effectiveness even when K2 is being supplemented.

3. Heart Support System Blend

Ones' proprietary Heart Support blend is designed around cardiovascular risk factors that include vascular calcification pathways. For individuals with elevated ucMGP, high CRP, or wearable-detected poor HRV, the Heart Support blend provides targeted support — including K2 and co-factors — calibrated to your individual risk signals rather than generic population averages.

Platforms like Thorne and Ritual offer vitamin K products, but neither ingests your actual blood markers to determine which form, dose, or co-factor combination is appropriate. Understanding how omega-3 EPA and DHA ratios interact with inflammatory pathways is another area where Ones uses your biomarker data to personalize your formula beyond what off-the-shelf supplements can offer.

---

Key Takeaways

• Vitamin K deficiency spans two distinct physiological domains: coagulation (K1, liver) and extrahepatic functions (K2/MK-7, bones and arteries). Most people are sufficient in the first and deficient in the second.
• Standard clotting labs miss early deficiency: ucOC and dp-ucMGP are the clinically validated markers for tissue-level K status — request these if you suspect insufficiency or are at risk.
• Vitamin D3 increases the demand for K2: High-dose D3 without MK-7 co-supplementation may worsen vascular calcification and fail to fully protect bone density. The combination is more effective than either nutrient alone.
• Fat-soluble vitamin deficiencies cluster together: If you have signs of vitamin A, D, E, or K deficiency, assess all four — especially if you have fat malabsorption, are on a very-low-fat diet, or take antibiotics regularly.
• B-vitamin deficiencies (B1, B6) can co-exist and amplify cardiovascular risk: Elevated homocysteine from B6 deficiency worsens the same arterial environment that ucMGP is supposed to protect — compound deficiencies compound risk.
• Personalized blood-work-based formulation outperforms generic supplements: Ones analyzes your actual markers to determine which K form, what dose, and which co-factors your specific profile requires — rather than applying a one-size-fits-all approach to a nutrient with highly individual absorption and utilization patterns.

Always consult a licensed healthcare provider before making changes to your supplement regimen, particularly if you take anticoagulant medications, have kidney disease, or have a diagnosed fat malabsorption condition.